Zealand Pharma Completes Enrollment in Phase 3 Trial of Dasiglucagon in Children with Congenital Hyperinsulinism (CHI) https://www.globenewswire.com/news-release/2022/02/15/2384858/0/en/Zealand-Pharma-Completes-Enrollment-in-Phase-3-Trial-of-Dasiglucagon-in-Children-with-Congenital-Hyperinsulinism-CHI.html company announcement